As one of only 27 centers in the U.S. to house the technology, WellSpan York (Pa.) Hospital is utilizing the power of precision AI to treat prostate cancer. Edward Steiner, MD, radiologist, medical ...
Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...
Mevrometostat in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate: The phase 3, randomized MEVPRO-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback